Department of Pharmacology, R R College of Pharmacy, Bangalore India.
Received on 09 April 2024; revised on 18 May 2024; accepted on 21 May 2024
Without a question, the two most significant biological targets for breast cancer are HER2 and CDK4/6. Anti-HER2 therapies improve overall survival, progression-free/disease-free survival, and objective response. Overall survival statistics are still pending, but three CDK4/6 inhibitors regularly increase progression-free survival and objective response. There is still a need for better endocrine therapies and chemotherapy optimisation. Particularly for triple-negative breast cancer, check point inhibitor-based immunotherapy in conjunction with chemotherapy is a promising area.
Herbal medicines; Anti-tumor; Anti-oxidant; Immune-suppressive; Flavonoids; Cancer; Phytochemicals; Camptothecin; Ixora; Anticancer activity
Preview Article PDF
Mainak Khan, Deeparani Urolagin, Ansari Aashif Raza Mohd Imtiyaz, Samir Panda and Maneswari Boro. A comprehensive study on: Allopathy and herbal therapy on breast cancer. International Journal of Science and Research Archive, 2024, 12(01), 2863–2873. Article DOI: https://doi.org/10.30574/ijsra.2024.12.1.0873






